Elixir Medical To Announce Data from Three Platforms Designed to Transform Cardiovascular Disease Treatment at EuroPCR 2024, Including Two Late-Breakers
Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, announced it will present long-term two-yea